EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Liquid Biopsy in Neuropsychiatric Disorders: A Step Closer to Precision Medicine

Perla El-Ahmad, Ana Paula Mendes-Silva, Breno S Diniz

Molecular Neurobiology · 2025-03 · 62 (3) · 3462-3479

DOI: 10.1007/s12035-024-04492-y ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Neurobiology, online erschienen am 19.09.2024. Verfasst von Perla El-Ahmad und 2 weiteren Autor:innen. Beteiligte Einrichtung: UConn Center on Aging, University of Connecticut Health Center, 263 Farmington Ave, Farmington, CT, 06030, USA. elahmad@uchc.edu. Hauptthemen laut MEDLINE: Mental Disorders, Precision Medicine, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 118 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psychiatric disorders are among the leading causes of disease burden worldwide. Despite their significant impact, their diagnosis remains challenging due to symptom heterogeneity, psychiatric comorbidity, and the lack of objective diagnostic tests and well-defined biomarkers. Leveraging genomic, epigenomic, and fragmentomic technologies, circulating cell-free DNA (ccfDNA)-based liquid biopsies have emerged as a potential non-invasive diagnosis and disease-monitoring tool. ccfDNA is a DNA species released into circulation from all types of cells through passive and active mechanisms and can serve as a biomarker for various diseases, namely, cancer. Despite their potential, the application of ccfDNA in neuropsychiatry remains underdeveloped. In this review, we provide an overview of liquid biopsies and their components, with a particular focus on ccfDNA. With a summary of pre-analytical practices and current ccfDNA technologies, we highlight the current state of research regarding the use of ccfDNA as a biomarker for neuropsychiatric disorders. Finally, we discuss future steps to unlock ccfDNA's potential in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mental DisordersPrecision MedicineCell-Free Nucleic AcidsHumansLiquid BiopsyBiomarkers

Stichwörter der Autor:innen

Cell-free DNACell-free Mitochondrial DNACell-free Nucleic AcidsLiquid Biopsy

Substanzen

Cell-Free Nucleic AcidsBiomarkers

Autor:innen und Institutionen

  • UConn Center on Aging, University of Connecticut Health Center, 263 Farmington Ave, Farmington, CT, 06030, USA. elahmad@uchc.edu.
  • Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, Canada.
  • Department of Psychiatry, University of Saskatchewan, Saskatoon, Canada.
  • UConn Center on Aging, University of Connecticut Health Center, 263 Farmington Ave, Farmington, CT, 06030, USA. diniz@uchc.edu.

Zitieren

APA

El-Ahmad, P., Mendes-Silva, A. P., & Diniz, B. S. (2025). Liquid Biopsy in Neuropsychiatric Disorders: A Step Closer to Precision Medicine. Molecular Neurobiology, 62(3), 3462-3479. https://doi.org/10.1007/s12035-024-04492-y

Vancouver

El-Ahmad P, Mendes-Silva AP, Diniz BS. Liquid Biopsy in Neuropsychiatric Disorders: A Step Closer to Precision Medicine. Molecular Neurobiology. 2025;62(3):3462-3479. doi:10.1007/s12035-024-04492-y

BibTeX
@article{ElAhmad2025,
  author = {El-Ahmad, Perla and Mendes-Silva, Ana Paula and Diniz, Breno S},
  title = {Liquid Biopsy in Neuropsychiatric Disorders: A Step Closer to Precision Medicine},
  journal = {Molecular Neurobiology},
  year = {2025},
  volume = {62},
  number = {3},
  pages = {3462--3479},
  doi = {10.1007/s12035-024-04492-y}
}
Kostenlos starten →